1. Cruz AA, Garcia DM, Pinto CT, Cechetti SP. Spontaneous eyeblink activity. Ocul Surf. 2011; 9:29–41. PMID:
21338567.
Article
2. van Koningsbruggen MG, Peelen MV, Davies E, Rafal RD. Neural control of voluntary eye closure: a case study and an fMRI investigation of blinking and winking. Behav Neurol. 2012; 25:103–109. PMID:
22530264.
Article
3. Esteban A, Traba A, Prieto J. Eyelid movements in health and disease. The supranuclear impairment of the palpebral motility. Neurophysiol Clin. 2004; 34:3–15. PMID:
15030796.
Article
4. Schmidtke K, Büttner-Ennever JA. Nervous control of eyelid function: a review of clinical, experimental and pathological data. Brain. 1992; 115 Pt 1:227–247. PMID:
1559156.
5. Esteban A, Gimenez-Roldan S. Involuntary closure of eyelids in parkinsonism: electrophysiological evidence for prolonged inhibition of the levator palpebrae muscles. J Neurol Sci. 1988; 85:333–345. PMID:
3210029.
6. Defazio G, Livrea P, Lamberti P, De Salvia R, Laddomada G, Giorelli M, et al. Isolated so-called apraxia of eyelid opening: report of 10 cases and a review of the literature. Eur Neurol. 1998; 39:204–210. PMID:
9635470.
Article
7. Nashold BS Jr, Gills JP, Wilson WP. Ocular signs of brain stimulation in the human. Confin Neurol. 1967; 29:169–174. PMID:
4232575.
8. Aramideh M, Ongerboer de, Koelman JH, Speelman JD. Motor persistence of orbicularis oculi muscle in eyelid-opening disorders. Neurology. 1995; 45:897–902. PMID:
7746403.
Article
9. Keam SJ, Muir VJ, Deeks ED. Botulinum toxin A (Dysport®): in dystonias and focal spasticity. Drugs. 2011; 71:1043–1058. PMID:
21668041.